CollPlant Biotechnologies
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CLGN and other ETFs, options, and stocks.About CLGN
CollPlant Biotechnologies Ltd. operates as a regenerative and aesthetic medicine company. It engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics.
CEOYehiel Tal
CEOYehiel Tal
Employees57
Employees57
HeadquartersRehovot, Tel Aviv
HeadquartersRehovot, Tel Aviv
Founded2004
Founded2004
Employees57
Employees57
CLGN Key Statistics
Market cap19.20M
Market cap19.20M
Price-Earnings ratio-1.63
Price-Earnings ratio-1.63
Dividend yield—
Dividend yield—
Average volume23.94K
Average volume23.94K
High today$1.65
High today$1.65
Low today$1.51
Low today$1.51
Open price$1.65
Open price$1.65
Volume24.63K
Volume24.63K
52 Week high$4.98
52 Week high$4.98
52 Week low$1.31
52 Week low$1.31
Stock Snapshot
With a market cap of 19.2M, CollPlant Biotechnologies(CLGN) trades at $1.51. The stock has a price-to-earnings ratio of -1.63.
As of 2025-12-16, CollPlant Biotechnologies(CLGN) stock has fluctuated between $1.51 and $1.65. The current price stands at $1.51, placing the stock 0.0% above today's low and -8.5% off the high.
CollPlant Biotechnologies(CLGN) shares are trading with a volume of 24.63K, against a daily average of 23.94K.
During the past year, CollPlant Biotechnologies(CLGN) stock moved between $1.31 at its lowest and $4.98 at its peak.
During the past year, CollPlant Biotechnologies(CLGN) stock moved between $1.31 at its lowest and $4.98 at its peak.
People also own
Based on the portfolios of people who own CLGN. This list is generated using Robinhood data, and it’s not a recommendation.